Presentation is loading. Please wait.

Presentation is loading. Please wait.

Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study  Jacques de Blic, MDa, Christophe Delacourt, MDa, Muriel.

Published byHenrik Skov Modified over 5 years ago

Similar presentations

Presentation on theme: "Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study  Jacques de Blic, MDa, Christophe Delacourt, MDa, Muriel."— Presentation transcript:

1 Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study 
Jacques de Blic, MDa, Christophe Delacourt, MDa, Muriel Le Bourgeois, MDa, Bruno Mahut, MDa, Juliette Ostinelli, MDb, Carole Caswell, MScc, Pierre Scheinmann, MDa  Journal of Allergy and Clinical Immunology  Volume 98, Issue 1, Pages (July 1996) DOI: /S (96)70221-X Copyright © 1996 Mosby, Inc. Terms and Conditions

2 FIG. 1 Percentage of patients without exacerbation of asthma in budesonide and placebo groups during treatment and follow-up periods. Journal of Allergy and Clinical Immunology  , 14-20DOI: ( /S (96)70221-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

3 FIG. 2 Proportion of days and nights with symptoms during the treatment period in the budesonide group (Solid Square) and in the placebo group (Open Square). (Values are expressed as means ± SD.) NS, Not significant. Journal of Allergy and Clinical Immunology  , 14-20DOI: ( /S (96)70221-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

Download ppt "Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study  Jacques de Blic, MDa, Christophe Delacourt, MDa, Muriel."

Similar presentations

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5- year follow-up: Effectiveness of early intervention with budesonide in.

The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5- year follow-up: Effectiveness of early intervention with budesonide in.
Tuomo Puhakka, MDa, Mika J

Tuomo Puhakka, MDa, Mika J
House dust mite avoidance measures improve peak flow and symptoms in patients with allergy but without asthma: A possible delay in the manifestation of.

House dust mite avoidance measures improve peak flow and symptoms in patients with allergy but without asthma: A possible delay in the manifestation of.
Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome  Paul Steinberg, MDa, Bruce E.

Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome  Paul Steinberg, MDa, Bruce E.
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Kiwi fruit allergy: A new birch pollen–associated food allergy

Kiwi fruit allergy: A new birch pollen–associated food allergy
Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: A randomized, double-blind, parallel group.

Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: A randomized, double-blind, parallel group.
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M

Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 
Ulrich Wahn, MDa. ‡, Eli O. Meltzer, MDb. ‡, Albert F. Finn, MDc

Ulrich Wahn, MDa. ‡, Eli O. Meltzer, MDb. ‡, Albert F. Finn, MDc
Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction  Robert A. Nathan, MDa, Jonathan A.

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction  Robert A. Nathan, MDa, Jonathan A.
Kiwi fruit allergy: A new birch pollen–associated food allergy

Kiwi fruit allergy: A new birch pollen–associated food allergy
Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.

Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.
Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,

Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Practice Notes from the AAAI

Practice Notes from the AAAI
David P. Skoner, MD, Betty L

David P. Skoner, MD, Betty L
Badrul A. Chowdhury, MD, PhD 

Badrul A. Chowdhury, MD, PhD 

Similar presentations

Ads by Google